Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap
Heart failure (HF) with preserved ejection fraction (EF; HFpEF) accounts for 50% of HF
cases, and its prevalence relative to HF with reduced EF continues to rise. In contrast to HF …
cases, and its prevalence relative to HF with reduced EF continues to rise. In contrast to HF …
The role of non-invasive devices for the telemonitoring of heart failure patients
A Faragli, D Abawi, C Quinn, M Cvetkovic… - Heart Failure …, 2021 - Springer
Heart failure (HF) patients represent one of the most prevalent as well as one of the most
fragile population encountered in the cardiology and internal medicine departments …
fragile population encountered in the cardiology and internal medicine departments …
[HTML][HTML] Predictive performance and impact of algorithms in remote monitoring of chronic conditions: A systematic review and meta-analysis
Background The use of telehealth interventions, such as the remote monitoring of patient
clinical data (eg blood pressure, blood glucose, heart rate, medication use), has been …
clinical data (eg blood pressure, blood glucose, heart rate, medication use), has been …
Biomarker profiling for risk of future heart failure (HFpEF) development
CJ Watson, J Gallagher, M Wilkinson… - Journal of Translational …, 2021 - Springer
Background The purpose of this study was to investigate the utility of BNP, hsTroponin-I,
interleukin-6, sST2, and galectin-3 in predicting the future development of new onset heart …
interleukin-6, sST2, and galectin-3 in predicting the future development of new onset heart …
Molecular mechanism of induction of bone growth by the C-type natriuretic peptide
The skeletal development process in the body occurs through sequential cellular and
molecular processes called endochondral ossification. Endochondral ossification occurs in …
molecular processes called endochondral ossification. Endochondral ossification occurs in …
Treatment of heart failure with preserved ejection fraction (HFpEF): the phenotype-guided approach
DN Silverman, SJ Shah - Current treatment options in cardiovascular …, 2019 - Springer
The syndrome of heart failure with preserved ejection (HFpEF) continues to rise in
prevalence without persuasive evidence of current pharmacologic interventions that can …
prevalence without persuasive evidence of current pharmacologic interventions that can …
Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1‐receptor agonist neladenoson bialanate in patients with chronic …
Despite major advances in the treatment of chronic heart failure (HF) with reduced ejection
fraction (HFrEF), morbidity and mortality associated with the condition remain high …
fraction (HFrEF), morbidity and mortality associated with the condition remain high …
Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study
K McDonald, R Troughton, U Dahlström… - European Journal of …, 2018 - Wiley Online Library
Background Serial measurement of natriuretic peptides may guide management in heart
failure (HF) patients. In previous trials, natriuretic peptides were infrequently monitored …
failure (HF) patients. In previous trials, natriuretic peptides were infrequently monitored …
[HTML][HTML] Point-of-care testing of (N-terminal pro) B-type natriuretic peptide for heart disease patients in home care and ambulatory care settings
N Shimizu, K Kotani - Practical laboratory medicine, 2020 - Elsevier
Objectives The role of point-of-care testing (POCT) out of hospital, especially in home care
and ambulatory care settings, is an issue meriting further research. We reviewed studies …
and ambulatory care settings, is an issue meriting further research. We reviewed studies …
Readmission risk factors and heart failure with preserved ejection fraction
D Harmon, J Rathousky, F Choudhry… - Journal of Osteopathic …, 2020 - degruyter.com
Context Cases of heart failure with preserved ejection fraction (HFpEF) exacerbations
continue to affect patients' quality of life and cause significant financial burden on our …
continue to affect patients' quality of life and cause significant financial burden on our …